Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9814708
SERIAL NO

15044655

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to new pharmaceutical compositions comprising benzoquinoline compounds, and methods to inhibit vesicular monoamine transporter 2 (VMAT2) activity in a subject for the treatment of chronic hyperkinetic movement disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AUSPEX PHARMACEUTICALS INC400 INTERPACE PARKWAY PARSIPPANY NJ 07054

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arthur, John Vista, US 23 349
Bradbury, Margaret Vista, US 17 228
Carter, John Vista, US 125 3249
Gant, Thomas Carlsbad, US 7 133
Shahbaz, Manouchehr San Diego, US 35 284
Sommer, Andreas Carlsbad, US 51 580
Zhang, Chengzhi San Diego, US 143 819

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 14, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 14, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00